ECT in pregnancy and the postpartum

Josephine Power, Richard Hiscock, Megan Galbally, Susan Walker, Timothy Rolfe

Research output: Chapter in Book/Conference paperChapter

Abstract

It is becoming increasingly well-established that maternal mental illness has a significant impact on the development of the fetus as well as the ability of the mother to parent her baby. For some women with severe mental illness in pregnancy pharmacological therapy can be problematic with a delay to response and therefore risk of maternal morbidity and mortality as well as the risks to the fetus. ECT has long been used as a treatment for severe mental illness and in some cases it may offer a viable option for treating these more severe disorders in pregnancy. When making a decision regarding treatment of mental illness in pregnancy it is important to have the available information regarding risks and benefits in order to guide treatment in the individual patient. In this chapter the relevant literature regarding ECT and pregnancy will be reviewed, and management guidelines offered for the implementation of ECT across pregnancy and early postpartum, including management of anaesthesia and fetal wellbeing during the period of treatment.

Original languageEnglish
Title of host publicationElectroconvulsive Therapy
Subtitle of host publicationClinical Uses, Efficacy and Long-Term Health Effects
EditorsKathleen Braddock
Place of PublicationUK
PublisherNova Science Publishers Inc
Pages33-62
Number of pages30
ISBN (Electronic)9781634630382
ISBN (Print)9781634630115
Publication statusPublished - 1 Jan 2014
Externally publishedYes

Fingerprint

Postpartum Period
Pregnancy
Fetus
Mothers
Therapeutics
Aptitude
Maternal Mortality
Decision Making
Anesthesia
Pharmacology
Guidelines
Morbidity

Cite this

Power, J., Hiscock, R., Galbally, M., Walker, S., & Rolfe, T. (2014). ECT in pregnancy and the postpartum. In K. Braddock (Ed.), Electroconvulsive Therapy: Clinical Uses, Efficacy and Long-Term Health Effects (pp. 33-62). UK: Nova Science Publishers Inc.
Power, Josephine ; Hiscock, Richard ; Galbally, Megan ; Walker, Susan ; Rolfe, Timothy. / ECT in pregnancy and the postpartum. Electroconvulsive Therapy: Clinical Uses, Efficacy and Long-Term Health Effects. editor / Kathleen Braddock. UK : Nova Science Publishers Inc, 2014. pp. 33-62
@inbook{643943b0d1994bcf8cc3109eb67b7093,
title = "ECT in pregnancy and the postpartum",
abstract = "It is becoming increasingly well-established that maternal mental illness has a significant impact on the development of the fetus as well as the ability of the mother to parent her baby. For some women with severe mental illness in pregnancy pharmacological therapy can be problematic with a delay to response and therefore risk of maternal morbidity and mortality as well as the risks to the fetus. ECT has long been used as a treatment for severe mental illness and in some cases it may offer a viable option for treating these more severe disorders in pregnancy. When making a decision regarding treatment of mental illness in pregnancy it is important to have the available information regarding risks and benefits in order to guide treatment in the individual patient. In this chapter the relevant literature regarding ECT and pregnancy will be reviewed, and management guidelines offered for the implementation of ECT across pregnancy and early postpartum, including management of anaesthesia and fetal wellbeing during the period of treatment.",
author = "Josephine Power and Richard Hiscock and Megan Galbally and Susan Walker and Timothy Rolfe",
year = "2014",
month = "1",
day = "1",
language = "English",
isbn = "9781634630115",
pages = "33--62",
editor = "Kathleen Braddock",
booktitle = "Electroconvulsive Therapy",
publisher = "Nova Science Publishers Inc",
address = "United States",

}

Power, J, Hiscock, R, Galbally, M, Walker, S & Rolfe, T 2014, ECT in pregnancy and the postpartum. in K Braddock (ed.), Electroconvulsive Therapy: Clinical Uses, Efficacy and Long-Term Health Effects. Nova Science Publishers Inc, UK, pp. 33-62.

ECT in pregnancy and the postpartum. / Power, Josephine; Hiscock, Richard; Galbally, Megan; Walker, Susan; Rolfe, Timothy.

Electroconvulsive Therapy: Clinical Uses, Efficacy and Long-Term Health Effects. ed. / Kathleen Braddock. UK : Nova Science Publishers Inc, 2014. p. 33-62.

Research output: Chapter in Book/Conference paperChapter

TY - CHAP

T1 - ECT in pregnancy and the postpartum

AU - Power, Josephine

AU - Hiscock, Richard

AU - Galbally, Megan

AU - Walker, Susan

AU - Rolfe, Timothy

PY - 2014/1/1

Y1 - 2014/1/1

N2 - It is becoming increasingly well-established that maternal mental illness has a significant impact on the development of the fetus as well as the ability of the mother to parent her baby. For some women with severe mental illness in pregnancy pharmacological therapy can be problematic with a delay to response and therefore risk of maternal morbidity and mortality as well as the risks to the fetus. ECT has long been used as a treatment for severe mental illness and in some cases it may offer a viable option for treating these more severe disorders in pregnancy. When making a decision regarding treatment of mental illness in pregnancy it is important to have the available information regarding risks and benefits in order to guide treatment in the individual patient. In this chapter the relevant literature regarding ECT and pregnancy will be reviewed, and management guidelines offered for the implementation of ECT across pregnancy and early postpartum, including management of anaesthesia and fetal wellbeing during the period of treatment.

AB - It is becoming increasingly well-established that maternal mental illness has a significant impact on the development of the fetus as well as the ability of the mother to parent her baby. For some women with severe mental illness in pregnancy pharmacological therapy can be problematic with a delay to response and therefore risk of maternal morbidity and mortality as well as the risks to the fetus. ECT has long been used as a treatment for severe mental illness and in some cases it may offer a viable option for treating these more severe disorders in pregnancy. When making a decision regarding treatment of mental illness in pregnancy it is important to have the available information regarding risks and benefits in order to guide treatment in the individual patient. In this chapter the relevant literature regarding ECT and pregnancy will be reviewed, and management guidelines offered for the implementation of ECT across pregnancy and early postpartum, including management of anaesthesia and fetal wellbeing during the period of treatment.

UR - http://www.scopus.com/inward/record.url?scp=84955095744&partnerID=8YFLogxK

UR - https://novapublishers.com/shop/electroconvulsive-therapy-clinical-uses-efficacy-and-long-term-health-effects/

M3 - Chapter

SN - 9781634630115

SP - 33

EP - 62

BT - Electroconvulsive Therapy

A2 - Braddock, Kathleen

PB - Nova Science Publishers Inc

CY - UK

ER -

Power J, Hiscock R, Galbally M, Walker S, Rolfe T. ECT in pregnancy and the postpartum. In Braddock K, editor, Electroconvulsive Therapy: Clinical Uses, Efficacy and Long-Term Health Effects. UK: Nova Science Publishers Inc. 2014. p. 33-62